INFLAMMATORY AND DEGENERATIVE ARTHRITIS: PATHOPHYSIOLOGY AND PRINCIPLES

Arthritis is a broad, encompassing term utilized to describe joint pain and subsequent articular destruction. While various arthritides share the common clinical endpoints of pain, deformity, and functional limitation, their underlying histopathology and molecular mechanisms differ profoundly. Because of these distinct etiologies, pharmaceutical management varies dramatically; however, the surgical treatment algorithms remain relatively uniform. Surgical intervention depends largely on the underlying biomechanical stability, the extent of joint involvement, the quality of the surrounding soft tissue envelope, and the severity of patient symptoms.

The heterotopic group of diseases classified as "arthritis" features underlying mechanisms ranging from primary mechanical "wear and tear" to trauma, sepsis, or systemic autoimmune disorders. Understanding the precise etiology is paramount for the orthopaedic surgeon, as it dictates perioperative medical management, the choice of surgical implants, and the anticipated timeline for postoperative healing.

Osteoarthritis: The Mechanical and Enzymatic Imbalance

Osteoarthritis (OA) represents a fundamental imbalance between the destructive and reparative processes of hyaline cartilage. Despite the long-held, antiquated belief that osteoarthritis is purely a natural aging process, contemporary evidence demonstrates that a joint must be subjected to aberrant mechanical stress or prior trauma to become arthritic. Normal, congruent joints subjected to moderate, physiologic stress should not degenerate over a standard human life span.

Although the exact molecular pathway of osteoarthritis continues to be elucidated, the primary enzymes responsible for articular degradation are well identified.
* Matrix Metalloproteinases (MMPs): Secreted by both synovial cells and chondrocytes, these enzymes cleave the collagen and proteoglycan framework of the extracellular matrix.
* Interleukin-1 (IL-1): A potent proinflammatory cytokine that actively induces the synthesis of MMPs while simultaneously suppressing the synthesis of type II collagen and aggrecan.

In the osteoarthritic joint, the concentration and activity of matrix metalloproteinases overwhelm the endogenous regulatory inhibitors (such as Tissue Inhibitors of Metalloproteinases, or TIMPs), resulting in progressive, irreversible joint degradation.

Inflammatory Arthritides: Rheumatoid Arthritis

The inflammatory arthritides encompass a spectrum of systemic diseases, including gout, systemic lupus erythematosus (SLE), psoriatic arthritis, and rheumatoid arthritis (RA). For the foot and ankle surgeon, rheumatoid arthritis represents one of the most common chronic inflammatory etiologies prompting patients to seek operative care.

Rheumatoid arthritis is characterized histologically by aggressive synovitis, the formation of rheumatoid nodules, and localized vasculitis. Within the musculoskeletal system, RA manifests as a persistent, symmetrical polyarthritis affecting the hands, feet, and virtually any synovial-lined joint.

Clinical Pearl: Almost 90% of adult patients with rheumatoid arthritis will develop symptomatic arthritis of the feet of varying severity during their disease course. Furthermore, approximately 17% of RA patients present initially with symptoms exclusively affecting the joints of the feet. Even mild-to-moderate RA has a profoundly negative impact on an individual’s mobility, gait biomechanics, and overall functional capacity.

Genetically, RA does not exhibit the simple Mendelian segregation patterns seen in single, high-penetrance gene disorders. Instead, most genomic studies support the concept that the actual disease-conferring sequence encompasses amino acids 67 through 74 of the HLA-DRB1 gene (the "shared epitope"). Joint destruction in RA results primarily from a complex interplay of T cells and B cells, which incite a cytokine cascade (TNF-alpha, IL-6) leading to the massive release of proteases and collagenases from chondrocytes and hyperplastic synovial fibroblasts (pannus).

Diagnostic Criteria for Rheumatoid Arthritis

The diagnosis of RA is clinical, supported by laboratory and radiographic findings. At least four of the following seven criteria must be present:
1. Morning stiffness lasting at least one hour.
2. Arthritis of three or more joint areas simultaneously.
3. Arthritis of the hand joints (swelling of PIP, MCP, or wrist joints).
4. Symmetrical arthritis.
5. Rheumatoid nodules (subcutaneous).
6. Serum rheumatoid factor (RF) positive.
7. Radiographic changes typical of RA on posteroanterior hand and wrist radiographs (must include erosions and unequivocal bony decalcification localized to or most marked adjacent to the involved joints).

Diagnostic Pitfall: Episodic pain is more often associated with an inflammatory process (e.g., crystal arthropathy or palindromic rheumatism). This history should prompt the clinician to investigate further if the diagnosis of primary osteoarthritis is uncertain. No single test result is absolutely confirmatory for RA; diagnosis relies on a synthesis of clinical, laboratory, and imaging features.

Seronegative Spondyloarthropathies

In stark contrast to rheumatoid arthritis, seronegative arthritides frequently involve the insertion sites of tendons and ligaments into bone—a condition termed enthesopathy or enthesitis. The most common seronegative arthritides include:
* Reactive Arthritis (formerly Reiter syndrome)
* Psoriatic Arthritis
* Ankylosing Spondylitis

Unlike rheumatoid arthritis, which exhibits a strong female predominance, the seronegative arthritides show a distinct male predominance, with the exception of psoriatic arthritis, which presents with a male-to-female ratio of 1:1. These diseases share a strong genetic association with Human Leukocyte Antigen (HLA) genes, particularly HLA-B27.

PREOPERATIVE EVALUATION AND BIOMECHANICS

Biomechanical Considerations in the Arthritic Foot

The foot and ankle function as a complex, multi-articulated shock absorber and rigid lever arm. In inflammatory arthritis, the destruction of capsuloligamentous structures leads to predictable patterns of deformity:
* Hindfoot: Talonavicular joint destruction leads to loss of the medial longitudinal arch, resulting in a severe pes planovalgus deformity. The subtalar joint often subluxates laterally.
* Forefoot: Synovitis of the metatarsophalangeal (MTP) joints attenuates the plantar plate and collateral ligaments. This results in hallux valgus, dorsal subluxation or dislocation of the lesser toes, and distal migration of the plantar fat pad, causing intractable plantar keratoses beneath the prominent metatarsal heads.

Perioperative Medical Optimization

Surgical intervention in the inflammatory arthritis patient requires meticulous perioperative coordination with a rheumatologist.
* Conventional DMARDs: Methotrexate can generally be continued perioperatively, as studies show continuing it does not increase infection risk and prevents disease flare.
* Biologic Agents: TNF-alpha inhibitors (e.g., etanercept, infliximab) should typically be withheld prior to surgery (timing depends on the drug's half-life, usually 1-4 weeks) and resumed once wound healing is complete (typically 14-21 days postoperatively) to mitigate the risk of devastating postoperative infections.
* Corticosteroids: Patients on chronic systemic corticosteroids may require perioperative "stress dose" steroids to prevent adrenal crisis, though recent literature suggests this is only necessary for highly invasive procedures in severely suppressed patients.

SURGICAL MANAGEMENT: INDICATIONS AND POSITIONING

Surgical Indications

Operative intervention is indicated when conservative measures (orthotics, rocker-bottom shoes, NSAIDs, intra-articular corticosteroid injections, and optimized DMARD therapy) fail to provide acceptable pain relief or when progressive deformity threatens skin integrity (e.g., impending ulceration over a prominent talar head or metatarsal head).

Patient Positioning and Anesthesia

• Anesthesia: Regional anesthesia (popliteal and saphenous nerve blocks) combined with monitored anesthesia care (MAC) or general anesthesia is preferred. Regional blocks provide excellent postoperative analgesia and reduce the need for systemic opioids.
• Positioning: The patient is placed supine on the operating table. A bump is placed under the ipsilateral hip to internally rotate the leg, bringing the foot into a neutral position (as the lower extremity naturally externally rotates when supine).
• Tourniquet: A thigh or calf tourniquet is applied. Warning: In patients with severe rheumatoid vasculitis or significant peripheral arterial disease, tourniquet use should be minimized or avoided entirely to prevent ischemic complications and delayed wound healing.

STEP-BY-STEP SURGICAL APPROACHES

1. Rheumatoid Forefoot Reconstruction (Hoffmann Procedure with 1st MTP Arthrodesis)

The gold standard for the severe rheumatoid forefoot (hallux valgus with dislocated lesser MTP joints) is arthrodesis of the first MTP joint combined with resection arthroplasty of the lesser metatarsal heads.

Step 1: First MTP Joint Arthrodesis
* Incision: A dorsal longitudinal incision is made just medial to the extensor hallucis longus (EHL) tendon, extending from the mid-proximal phalanx to the mid-first metatarsal.
* Exposure: The capsule is incised longitudinally. Full-thickness flaps are elevated to expose the MTP joint. The collateral ligaments are released to allow joint subluxation.
* Joint Preparation: Using a combination of sagittal saws, cup-and-cone reamers, or rongeurs, the articular cartilage and subchondral bone of the metatarsal head and the base of the proximal phalanx are removed until bleeding cancellous bone is exposed.
* Positioning: The hallux is positioned in 10 to 15 degrees of valgus, 10 to 15 degrees of dorsiflexion (relative to the first metatarsal), and neutral rotation.
* Fixation: Fixation is typically achieved with a dorsal neutralization plate and a lag screw crossing the arthrodesis site.

Step 2: Lesser Metatarsal Head Resection
* Incisions: Two dorsal longitudinal incisions are typically used: one centered between the 2nd and 3rd metatarsals, and one between the 4th and 5th metatarsals. (Alternatively, a transverse plantar approach can be used, though dorsal incisions are preferred for wound healing).
* Resection: The extensor tendons are retracted. The MTP joint capsules are opened. The metatarsal necks are identified. Using an oscillating saw, the metatarsal heads are resected at the surgical neck. The resection should follow a smooth cascade, with the 2nd metatarsal being the longest and the 5th being the shortest.
* Soft Tissue Balancing: Extensor tenotomies or lengthenings may be required if the toes remain dorsally contracted.
* Pinning: Smooth Kirschner wires (K-wires) (0.045 or 0.062 inch) are driven antegrade through the toes and then retrograde into the metatarsal shafts to maintain alignment.

Surgical Warning: Aggressive handling of the soft tissues in rheumatoid patients can lead to disastrous skin necrosis. Employ meticulous, full-thickness flap elevation and avoid excessive self-retaining retractor tension.

2. Hindfoot Arthrodesis (Triple Arthrodesis)

For severe pes planovalgus secondary to inflammatory or degenerative arthritis of the hindfoot, a triple arthrodesis (fusion of the subtalar, talonavicular, and calcaneocuboid joints) provides powerful deformity correction and pain relief.

Step 1: Lateral Approach
* Incision: An extensile lateral incision is made from the tip of the lateral malleolus extending distally toward the base of the 4th metatarsal.
* Exposure: The sural nerve is identified and protected. The extensor digitorum brevis (EDB) muscle belly is elevated from the calcaneus and reflected distally.
* Joint Preparation: The subtalar and calcaneocuboid joints are exposed. Articular cartilage is meticulously denuded using curettes, osteotomes, and high-speed burrs down to bleeding subchondral bone.

Step 2: Medial Approach
* Incision: A medial longitudinal incision is made centered over the talonavicular joint, between the anterior tibial and posterior tibial tendons.
* Exposure: The capsule is incised, and the talonavicular joint is exposed. The cartilage is removed. This joint is often the primary driver of the deformity and requires careful preparation.

Step 3: Deformity Correction and Fixation
* Correction: The hindfoot is manually corrected out of valgus. The talonavicular joint is reduced, restoring the medial longitudinal arch.
* Fixation Sequence:
1. Talonavicular Joint: Fixed first to establish the arch, typically with two large fragment (6.5mm or 7.0mm) cannulated screws or a specialized compression plate.
2. Subtalar Joint: Fixed second, usually with one or two large cannulated screws placed from the posterior calcaneal tuberosity into the body of the talus.
3. Calcaneocuboid Joint: Fixed last, using a plate or staples.
* Bone Grafting: Autologous bone graft (from the proximal tibia or iliac crest) or allograft is packed into any remaining voids to promote osteogenesis.

POSTOPERATIVE PROTOCOLS AND REHABILITATION

The postoperative management of the arthritic foot reconstruction requires strict adherence to immobilization protocols to ensure osseous union, particularly in patients with compromised biology (e.g., RA patients on immunosuppressants).

• Phase 1 (Weeks 0-2): The patient is placed in a bulky, well-padded posterior splint. Strict non-weight-bearing (NWB) status is enforced. Elevation above the level of the heart is critical to minimize edema and protect the fragile incisions.
• Phase 2 (Weeks 2-6): Sutures are removed at 2 to 3 weeks, provided the wounds are fully epithelialized. The patient is transitioned to a short-leg fiberglass cast or a rigid fracture boot. NWB status is maintained. For forefoot reconstructions, K-wires are typically pulled in the clinic at 4 to 6 weeks.
• Phase 3 (Weeks 6-12): Radiographs are obtained to assess for bridging trabecular bone. If clinical and radiographic signs of union are present, the patient begins progressive weight-bearing in a CAM boot. Physical therapy is initiated to focus on proximal muscle strengthening and gait training.
• Phase 4 (Months 3+): Transition to supportive, wide-toe-box footwear, often requiring custom orthotics or a rigid carbon fiber shank to protect the arthrodesis sites.

COMPLICATIONS AND PITFALLS

Orthopaedic surgeons must be acutely aware of the complications inherent to operating on inflammatory and degenerative arthritic conditions:

1. Wound Dehiscence and Infection: RA patients have thin, friable skin and are often on immunosuppressive medications. The risk of superficial and deep surgical site infections is significantly elevated. Meticulous soft tissue handling and appropriate perioperative management of biologics are mandatory.
2. Nonunion / Delayed Union: The systemic inflammatory state, combined with medications like methotrexate and corticosteroids, impairs osteogenesis. Rigid internal fixation and the liberal use of bone graft are essential to mitigate this risk.
3. Malunion: Fusing the 1st MTP joint in excessive plantarflexion will cause severe interphalangeal joint arthritis and dorsal ulceration. Fusing the hindfoot in varus will lead to lateral column overload and intractable pain. Precise intraoperative fluoroscopy is non-negotiable.
4. Hardware Prominence: Due to the lack of subcutaneous fat in the rheumatoid foot, plates and screw heads frequently become symptomatic, necessitating hardware removal once solid arthrodesis is achieved.

By adhering to strict biomechanical principles, respecting the compromised soft tissue envelope, and executing precise surgical techniques, the orthopaedic surgeon can reliably restore function and alleviate the debilitating pain associated with inflammatory and degenerative arthritis of the foot and ankle.